• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 1997

View Archived Issues

Combination of MKC-442, zidovudine and lamivudine highly effective in vitro

Read More

Combined blockade of 5-HT1A and 5-HT1B receptors potentiates fluoxetine activity

Read More

Positive clinical results for amylin analogue in diabetes

Read More

Myriad Genetics granted patent on MTS1 melanoma gene

Read More

New antitumor agents from Banyu

Read More

Analgesics reported by Daiichi and Fuji

Read More

Kyowa Hakko claims analgesic agents

Read More

Potent and selective ETA antagonists from Shionogi

Read More

Positive phase II results for Hycamtin in small cell lung cancer

Read More

N-Oxide oxazolidinones from Pharmacia & Upjohn

Read More

Novel semisynthetic macrolide immunosuppressants disclosed by Abbott

Read More

nAChR ligands prepared by Novo Nordisk

Read More

Warner-Lambert reveals agents with dual dopaminergic/serotonergic activity

Read More

British Biotech and SynPhar sign research collaboration

Read More

Kowa/Vrije University researchers identify potent CysLT1 receptor antagonists

Read More

Cell Genesys files IND for cancer gene therapy

Read More

BioChem Pharma's BCH-4556 to enter U.S. phase I trial in cancer

Read More

Immunomedics files IND for humanized lymphoma antibody

Read More

Rotterdam study assesses risk factors for dementia and AD

Read More

SmithKline Beecham's Androderm now available as a single patch system

Read More

Population-based study of postmenopausal ERT and risk of AD

Read More

Gene Logic and Johns Hopkins University enter into research collaboration

Read More

CombiChem and Teijin extend collaborative agreement

Read More

Riboflavin shows promise for migraine prophylaxis

Read More

Genentech plans phase III studies of second-generation t-PA

Read More

Alniditan more effective than sumatriptan in animal model of migraine

Read More

BioCryst receives milestone payment from Torii

Read More

Phase I/II prostate cancer studies under way for DUROS leuprolide

Read More

Fosamax cleared as preventive medication in osteoporosis

Read More

ANDA filed for Biovail generic calcium channel blocker

Read More

FDA clears generic antidepressant from Teva

Read More

DEA recommends descheduling of Redux

Read More

Nicotine inhaler cleared by FDA

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe